Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2026)
Spero Therapeutics posted quarterly Prepaid Assets of $1.4 million for Q1 2026, down 7.04% year-on-year from $1.5 million in Q1 2025, and down 11.93% on a QoQ basis from $1.6 million in Q4 2025.
Spero Therapeutics (SPRO) has 11 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 7.04% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 7.04% YoY), and the FY2025 full-year result was $1.6 million, down 14.5% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $8.7 million in Q1 2022 and bottomed at $1.2 million in Q3 2025.
- The 5-year median for Prepaid Assets is $3.2 million (2024), against an average of $3.4 million.
- The widest annual swing landed in 2022, when Prepaid Assets tumbled 74.2%; it then soared 263.44% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $3.4 million in 2022, then advanced by 23.65% to $4.2 million in 2023, then plunged by 54.26% to $1.9 million in 2024, then dropped by 14.5% to $1.6 million in 2025, then declined by 11.93% to $1.4 million in 2026.
- The last three Prepaid Assets figures came in at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 4.18 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Jun 30, 2023 | 8.57 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 8.75 Mn |
| Dec 31, 2021 | 8.83 Mn |
| Sep 30, 2021 | 5.77 Mn |
| Jun 30, 2021 | 4.90 Mn |
| Mar 31, 2021 | 5.19 Mn |
| Dec 31, 2020 | 6.06 Mn |
| Sep 30, 2020 | 7.30 Mn |
| Jun 30, 2020 | 9.16 Mn |
| Mar 31, 2020 | 5.68 Mn |
| Dec 31, 2019 | 4.82 Mn |
| Sep 30, 2019 | 3.68 Mn |
| Jun 30, 2019 | 6.29 Mn |
| Mar 31, 2019 | 7.93 Mn |
| Dec 31, 2018 | 7.48 Mn |
| Sep 30, 2018 | 1.22 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 1.22 Mn |
| Dec 31, 2017 | 1.83 Mn |
| Sep 30, 2017 | 1.05 Mn |
| Dec 31, 2016 | 1.25 Mn |